» Articles » PMID: 19441103

Association Between Dietary Nutrient Composition and the Incidence of Cirrhosis or Liver Cancer in the United States Population

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2009 May 15
PMID 19441103
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Little is known about the impact of dietary factors on the progression of liver disease. Our aim was to determine whether dietary intake was associated with the risk of cirrhosis-related or liver cancer-related death or hospitalization in the U.S. population. Participants included 9221 persons aged 25-74 years without evidence of cirrhosis at entry into the study or during the first 5 years of follow-up, who were subsequently followed for a mean of 13.3 years as part of the first National Health and Nutrition Examination Survey. Dietary intake was ascertained at baseline using a 24-hour dietary recall questionnaire. During follow-up, 123 of 9221 participants had a diagnosis of cirrhosis (n = 118) or liver cancer (n = 5) in hospitalization records or death certificates, including 36 who were diagnosed only on the basis of death certificates. Participants who reported a diet high in protein were at a higher risk of hospitalization or death due to cirrhosis or liver cancer (P = 0.001), whereas those who reported a diet high in carbohydrates were at a lower risk (P = 0.003), after adjusting for potential confounders (daily consumption of protein, carbohydrate, fat, tea or coffee, and alcohol, gender, race, age, educational attainment, U.S. geographical region, diabetes, body mass index, and subscapular-to-triceps skinfold ratio). Although total fat consumption was not significantly associated with the risk of cirrhosis or liver cancer, cholesterol consumption was associated with higher risk (P = 0.007), whereas serum cholesterol level was not associated with risk of cirrhosis or liver cancer.

Conclusion: Diet may be an important and potentially modifiable determinant of liver disease.

Citing Articles

Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study.

Tabar M, Nilghaz M, Hekmatdoost A, Pashayee-Khamene F, Mokhtari Z, Karimi S Sci Rep. 2025; 15(1):4798.

PMID: 39922975 PMC: 11807124. DOI: 10.1038/s41598-025-89433-y.


Free Cholesterol-Induced Liver Injury in Non-Alcoholic Fatty Liver Disease: Mechanisms and a Therapeutic Intervention Using Dihydrotanshinone I.

Shou J, Ma J, Wang X, Li X, Chen S, Kang B Adv Sci (Weinh). 2024; 12(2):e2406191.

PMID: 39558866 PMC: 11727260. DOI: 10.1002/advs.202406191.


Hepatic changes following a high-fat diet: effects of and gold nanoparticles phytoreduced with on oxidative stress, inflammation, and histological damage.

Zugravu D, Popa S, Pop A, Moldovan R, Tabaran A, David L Med Pharm Rep. 2024; 97(3):318-329.

PMID: 39234459 PMC: 11370864. DOI: 10.15386/mpr-2775.


Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.

Hermanson J, Tolba S, Chrisler E, Leone V J Nutr Biochem. 2024; 133:109704.

PMID: 39029595 PMC: 11480923. DOI: 10.1016/j.jnutbio.2024.109704.


Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives.

Butera E, Termite F, Esposto G, Galasso L, Mignini I, Borriello R Int J Mol Sci. 2024; 25(13).

PMID: 39000046 PMC: 11241610. DOI: 10.3390/ijms25136938.